Patent litigation has been amicably resolved and the parties have agreed to dismiss the patent claims.
We continue to have a robust pipeline at Abbott. There are a number of exciting things coming up...
People did need ample time to be able to transition to an alternative therapy.
The cases that were cited by FDA were not new.